Explorer les evidences

250 700 000 DALYsNeurological disorders ranked as the leading cause group of disability-adjusted life-years (DALYs) in 2015, with 250.7 million DALYs, comprising 10.2% of global DALYs.

Camerounneurological disordersobservé 2015publié 2017The Lancet. Neurologyeurope_pmcdocument de 10 observations

100 000 peopleHIV-1 group O is estimated to have infected around 100,000 people.

CamerounHIV-1 group Opublié 2015Proceedings of the National Academy of SciencesOpenAlexdocument de 2 observationsDOI 10.1073/pnas.1502022112

3,8 %HIV prevalence in the military of the Democratic Republic of Congo was 3.8%, higher than the general population prevalence of 1.3%.

CamerounVIH/sidapublié 2015International journal of STD & AIDSeurope_pmcdocument de 6 observations

5 yearsThe mean duration of diabetes was 5±3 years.

Cameroundiabète de type 1publié 2017BMJ open diabetes research & careeurope_pmcdocument de 7 observations

2,8 %The A71V mutation was identified in 2.8% of the 142 HIV-1 isolates in the protease gene.

CamerounVIH/sidapublié 2000Journal of Clinical MicrobiologyOpenAlexdocument de 19 observations

6,6 %Borderline hypertension was detected in 6.6% of urban women in Cameroon.

Camerounborderline hypertensionpublié 1998International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/27.2.181

24 %Training increased mid-thigh muscle cross-sectional area by 24% in middle-aged men with type 2 diabetes.

Cameroundiabète de type 2publié 2003European journal of endocrinologyeurope_pmcdocument de 3 observationsDOI 10.1530/eje.0.1490421

50,4 %Fifty-seven (50.4%) of the patients with diabetes had hypertension.

Cameroundiabète (non précisé) · hypertension artérielleobservé 2019publié 2022The Pan African medical journaleurope_pmcdocument de 10 observations

8,1 %At the community level, 7 of the 78 communities surveyed in the Monatélé HD had a prevalence of SCE exceeding 5.0%, with the highest values in Levem (8.1%), Mong (6.9%), Nkol-Melong (6.5%) and Nlongbong II (6.0%).

CamerounSCEHAL · Unilimdocument de 53 observations

29 %Depressive symptoms (PHQ-9 score ≥5) were reported in 29.0% of patients with type 2 diabetes treated with oral glucose-lowering drugs only.

Cameroundepressive symptoms · diabète de type 2observé 2011publié 2021Diabetes careeurope_pmcdocument de 4 observations

3 265 per_100000Self-harm and interpersonal violence had an age-standardised prevalence of 3265 cases per 100,000 in males in 2017.

Camerounself-harm and interpersonal violenceobservé 2017publié 2018Lancet (London, England)europe_pmcdocument de 14 observations

24,9 kg/m2The age-standardized mean BMI increased from 24.9 kg/m2 to 24.9 kg/m2 in women in sub-Saharan African countries between 1980 and 2014.

Camerounbody mass indexobservé 2014publié 2017International journal of epidemiologyeurope_pmcdocument de 11 observationsDOI 10.1093/ije/dyx078

5,4 %The age-standardized prevalence of hypertension was 5.4% in rural men in Cameroon.

Camerounhypertension artériellepublié 1998International journal of epidemiologyeurope_pmcdocument de 10 observationsDOI 10.1093/ije/27.2.181

15,1 %Among hypertensive participants in Cameroon, 15.1% [95% CI 10.6–19.6] were taking antihypertensive medications.

Camerounhypertension artériellepublié 2019Journal of hypertensioneurope_pmcdocument de 20 observationsDOI 10.1097/hjh.0000000000002165

124 100 000 DALYsIn 2016, smoking was the leading risk factor in terms of attributable DALYs for men globally, with 124.1 million DALYs.

Camerounsmokingobservé 2016publié 2017Lancet (London, England)europe_pmcdocument de 16 observationsDOI 10.1016/s0140-6736(17)32366-8

284 000 deathsDeaths from substance use disorders increased from 284,000 globally in 2007 to 352,000 in 2017.

Camerounsubstance use disordersobservé 2007publié 2018Lancet (London, England)europe_pmcdocument de 15 observations

1,32 %The prevalence of epilepsy recorded by the CDDs across all districts was 1.32%.

CamerounépilepsieHAL · Unilimdocument de 53 observations

612 patients612 sickle cell disease patients and 149 healthy controls were included in the CADRE study in Cameroon, Mali, and Senegal.

Cameroun · Mali · SénégaldrépanocytoseHAL · Unilimdocument de 2 observations

25 %Age-standardised adult diabetes prevalence in 2014 was nearly 25% in Polynesia and Micronesia.

Cameroundiabète (non précisé)observé 2014publié 2016Lancet (London, England)europe_pmcdocument de 7 observationsDOI 10.1016/s0140-6736(16)00618-8

10,2 %Among 128 patients routinely receiving highly active antiretroviral therapy in an HIV/AIDS outpatient clinic in Cameroon, 10.2% had resistance to non-NRTIs.

CamerounVIH/sidapublié 2006Emerging infectious diseasesOpenAlexdocument de 4 observationsDOI 10.3201/eid1206.050860

37 %Serologic testing yielded 40 false-negative samples (37.0%) for RH5 antigen testing.

CameroundrépanocytoseHAL · Unilimdocument de 45 observations

65,2 %SARS-CoV-2 PCR was negative at day 10 in 60 out of 92 participants (65.2%) allocated to doxycycline.

CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838

0,7 %Epilepsy represents 0.7% of the global burden of disease, as assessed by disability-adjusted life years (DALY).

CamerounépilepsieHAL · Unilimdocument de 53 observations

15 %Among HIV-1 protease (PR) sequences from drug-naïve Cameroonians, the secondary PI resistance-associated mutation 20R was present in 15% of strains.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

4 000 deathsCameroon reports almost 4,000 malaria deaths each year.

CamerounpaludismeHAL · Unilimdocument de 106 observations